A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT06140485
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 400 participants
- Sponsor
- Natural Wellness Egypt
- Registry
-
NCT06140485
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06140485. Randomized; triple masking; primary purpose treatment. Start 2024-03 (anticipated); primary completion 2025-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Dietary supplement)
- NW Low-Glu®
- Intervention (Drug)
- Metformin
- Lead sponsor
- Natural Wellness Egypt
Record details
- Record id
cardio:ct-nct06140485- Content hash
df3ff65354ca56314ec4358ec35910ad37b5ee397ecd858347cac516484f6e92